Markets:

Overview

News

Currencies

International

Treasuries

Fate Therapeutics, Inc. - Common Stock (NQ:FATE)

1.040 +0.010 (+0.97%)

Streaming Delayed Price Updated: 10:23 AM EST, Dec 2, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Fate Therapeutics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain ↗

September 14, 2021

Positive news versus poor clinical trial results may determine the future of Fate Therapeutics.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For August 26, 2021 ↗

August 26, 2021

Upgrades Scotiabank upgraded the previous rating for Enerplus Corp (NYSE:

Via Benzinga

Benchmarks Pivot Higher Ahead of Volatile Week's End ↗

August 20, 2021

The major indexes rebounded from their pre-market slide soon after the open, with help from big-name tech names, though all three are still on track for weekly losses.

Via Talk Markets

58 Biggest Movers From Friday ↗

August 23, 2021

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) shares climbed 204.1% to close at $19.16 on Friday. Regencell Bioscience reported partial exercise of underwriter...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 20, 2021

Gainers Regencell Bioscience (NASDAQ:RGC) shares rose 175.07% to $17.33 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 277....

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

August 20, 2021

Gainers GeoVax Labs, Inc. (NASDAQ: GOVX) shares climbed 45.8% to $6.27 after the company presented data from ongoing studies of its preventive vaccine against COVID-19, showing...

Via Benzinga

Why Fate Therapeutics Stock Is Sliding Today ↗

August 20, 2021

The positive results the company announced after the bell yesterday didn't meet some lofty expectations.

Via The Motley Fool

Mid-Morning Market Update: Markets Rise; Deere Beats Q3 Expectations ↗

August 20, 2021

Following the market opening Friday, the Dow traded up 0.42% to 35,041.98 while the NASDAQ rose 0.86% to 14,667.29. The S&P also rose, gaining 0.52% to 4,428.90. The U.S. has...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

August 20, 2021

Gainers Geovax Labs (NASDAQ:GOVX) shares...

Via Benzinga

11 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 20, 2021

Gainers Geovax Labs (NASDAQ:GOVX) stock moved upwards by 74.65% to $7.51. The market value of their outstanding shares is at $47.5 million. Agile Therapeutics (NASDAQ:AGRX...

Via Benzinga

Fate Therapeutics' Stem Cell-Derived NK Lymphoma Candidate Casts Doubt Over Durability Of Response ↗

August 20, 2021

Fate Therapeutics Inc (NASDAQ: FATE) revealed an early cut of Phase I data for its FT596 and FT516 programs for relapsed / refractory B-cell lymphoma. At the 2021...

Via Benzinga

Fate Stock Collapses As Investors Question Its Cancer Drug's Durability ↗

August 19, 2021

Fate Therapeutics unveiled mixed results for its lymphoma treatment late Thursday, and Fate stock crumbled in after-hours action.

Via Investor's Business Daily

The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow ↗

August 15, 2021

Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to dominate the headlines, with small-...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Fate Therapeutics, inc (FATE) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

FATE earnings call for the period ending June 30, 2021.

Via The Motley Fool

Topics Earnings

Did You See What Cathie Wood Bought on Wednesday? ↗

July 22, 2021

ARK Invest added to its stakes in DraftKings, Fate Therapeutics, and Zoom Video, all of which are trading well below their recent peaks.

Via The Motley Fool

Unusual Options Activity Insight: Fate Therapeutics ↗

July 12, 2021

On Monday, shares of Fate Therapeutics (NASDAQ:FATE) saw unusual options activity. After the option alert, the stock price moved down to $88. Sentiment: BEARISH Option Type:...

Via Benzinga

Elliott Wave Technical Analysis For Six US Stocks - CDNA, CRWD, FATE, UPS, HDB, SPOT ↗

July 03, 2021

CareDx, CrowdStrike, Fate Therapeutics, HDFC Bank, Spotify, UPS - Daily charts.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2021 ↗

June 07, 2021

Upgrades Deutsche Bank upgraded the previous rating for Marriott Vacations Worldwide Corp (NYSE:VAC) from Hold to Buy. Marriott Vacations earned $0.49 in the first quarter...

Via Benzinga

The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗

August 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Fate Therapeutics Stock is Trading Higher on Positive B-Cell Lymphoma Data at ASCO21 ↗

June 04, 2021

Fate Therapeutics Inc (NASDAQ: FATE) has revealed some new data from an ongoing Phase 1 trial evaluating FT516 for patients with relapsed / refractory B-cell...

Via Benzinga

The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗

May 31, 2021

After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...

Via Benzinga

Fate Therapeutics' iPSC-Derived Cell Therapies Induce Leukemic Blast Clearance, Show Durable Remissions In AML Patients ↗

May 14, 2021

Fate Therapeutics Inc (NASDAQ: FATE) has announced interim data from Phase 1 data from the Company's off-the-shelf, iPSC-derived natural killer (NK) cell...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 13, 2021

Gainers Bionano Genomics (NASDAQ:BNGO) st...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Data In Breast Cancer, Curis, Evoke Slump On Earnings, Qiagen's Rapid COVID-19 Antibody Test OK'ed For Emergency Use ↗

May 13, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Alexion Pharmaceuticals, Inc...

Via Benzinga

Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...

Via Benzinga

Cathie Wood Loads Up Another $28M Worth Of Shares In Alibaba Rival JD.Com ↗

May 09, 2021

Cathie Wood-led Ark Investment Management on Friday bought 366,879 shares, worth about $27.7 million, in JD.com Inc (NASDAQ: JD), a key rival to Alibaba Group Holding (NYSE: BABA...

Via Benzinga

Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗

May 10, 2021

Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.